MicroRNA-134 modulates resistance to doxorubicin in human breast cancer cells by downregulating ABCC1

Lu, Lin; Ju, Fang; Zhao, Hui; Ma, Xuezhen
December 2015
Biotechnology Letters;Dec2015, Vol. 37 Issue 12, p2387
Academic Journal
Objectives: To investigate the role of microRNAs in doxorubicin resistance of breast cancer cells. Results: MicroRNA-134 was down-regulated in doxorubicin-resistant and doxorubicin-sensitive breast cancer samples and MCF-7/ADR cell lines. After transfection of miR-134 mimics, an MTT assay confirmed that the MCF-7/ADR cell proliferation was inhibited. In the presence of doxorubicin, there was inhibition of cell proliferation. Transfection of miR-134 mimics induced MCF-7/ADR cell apoptosis. The expression of ABCC1 was significantly upregulated in doxorubicin-resistant or -sensitive breast cancer tissues and MCF-7/ADR cell lines. Over-expression of miR-134 decreased the expression of ABCC1 at the protein level. Conclusion: MicroRNA-134 modulates resistance to doxorubicin in breast cancer cells by downregulating the expression of ABCC1 which is known to encode the multidrug resistance-associated protein 1.


Related Articles

  • Association of microRNAs and pathologic response to preoperative chemotherapy in triple negative breast cancer: preliminary report. Kolacinska, Agnieszka; Morawiec, Jan; Fendler, Wojciech; Malachowska, Beata; Morawiec, Zbigniew; Szemraj, Janusz; Pawlowska, Zofia; Chowdhury, Dipanjan; Choi, Young; Kubiak, Robert; Pakula, Lukasz; Zawlik, Izabela // Molecular Biology Reports;May2014, Vol. 41 Issue 5, p2851 

    Triple negative breast cancer (TNBC) has caught the attention of oncologists worldwide because of poor prognosis and paucity of targeted therapies. Gene pathways have been widely studied, but less is known about epigenetic factors such as microRNAs (miRNAs) and their role in tailoring an...

  • MicroRNA-205 increases the sensitivity of docetaxel in breast cancer. YANG CAI; XIANG YAN; GUOQING ZHANG; WEIHONG ZHAO; SHUNCHANG JIAO // Oncology Letters;Feb2016, Vol. 11 Issue 2, p1105 

    Chemotherapy has been widely used in breast cancer therapy, but the efficacy of chemotherapy is intimately associated with the sensitivity of therapeutic drugs to breast cancer. Docetaxel is a first-line chemotherapeutic drug in breast cancer treatment, but further improvement to its efficacy...

  • Targeted Expression of miR-34a Using the T-VISA System Suppresses Breast Cancer Cell Growth and Invasion. Li, Laisheng; Xie, Xinhua; Luo, Jinmei; Liu, Min; Xi, Shaoyan; Guo, Jiaoli; Kong, Yanan; Wu, Minqing; Gao, Jie; Xie, Zeming; Tang, Jun; Wang, Xi; Wei, Weidong; Yang, Mingtian; Hung, Mien-Chie; Xie, Xiaoming // Molecular Therapy;Dec2012, Vol. 20 Issue 12, p2326 

    Recurrence and metastasis result in a poor prognosis for breast cancer patients. Recent studies have demonstrated that microRNAs (miRNAs) play vital roles in the development and metastasis of breast cancer. In this study, we investigated the therapeutic potential of miR-34a in breast cancer. We...

  • Ionizing Radiation Sensitizes Breast Cancer Cells to Bcl-2 Inhibitor, ABT-737, through Regulating Mcl-1. Wu, Hao; Schiff, Devora S.; Lin, Yong; Neboori, Hanmanth J. R.; Goyal, Sharad; Feng, Zhaohui; Haffty, Bruce G. // Radiation Research;Dec2014, Vol. 182 Issue 6, p618 

    Breast-conserving surgery followed by radiation therapy has become the standard of care for early stage breast cancer. However, there are some patients that develop a local failure. We have previously shown that Bcl-2 overexpression was associated with an increased risk of local recurrence in...

  • Deregulation of miR-21 and miR-p155 and their putative targets after silibinin treatment in T47D breast cancer cells. Zadeh, Masoud Maleki; Ranji, Najmeh; Motamed, Nasrin // Iranian Journal of Basic Medical Sciences;Dec2015, Vol. 18 Issue 12, p1210 

    ): MicroRNAs (miRNAs) are a class of short RNAs that control the biological processes including cell proliferation, apoptosis and development. Aberrant expression of miRNAs was determined in the different stages of tumor development and metastasis. To study the effect of silibinin on miRNAs...

  • Anti-proliferative effect of Klimaktoplan on human breast cancer cells. Ahn, Ki; Yi, Kyung; Park, Hyun; Shin, Jung; Hur, Jun; Kim, Sun; Kim, Tak // Archives of Gynecology & Obstetrics;Oct2013, Vol. 288 Issue 4, p833 

    Objective: With the health concerns of menopausal hormone replacement therapy, alternatives have been sought. Klimaktoplan is a homeopathic formulation consisting of four main components and has been used for relief of menopausal symptoms for a long time. The study investigated the safety of...

  • Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancer. Shuiliang Wang; Jingcao Huang; Hui Lyu; Bo Cai; Xiaoping Yang; Fang Li; Jianming Tan; Edgerton, Susan M.; Thor, Ann D.; Choon-Kee Lee; Bolin Liu // Breast Cancer Research;2013, Vol. 15 Issue 5, p2 

    Introduction Elevated expression of erbB3 rendered erbB2-overexpressing breast cancer cells resistant to paclitaxel via PI-3K/Akt-dependent upregulation of Survivin. It is unclear whether an erbB3- targeted therapy may abrogate erbB2-mediated paclitaxel resistance in breast cancer. Here, we...

  • Effects of SMYD3 over-expression on cell cycle acceleration and cell proliferation in MDA-MB-231 human breast cancer cells. Ren, Tian-nian; Wang, Jing-song; He, Yun-mian; Xu, Chang-liang; Wang, Shu-zhen; Xi, Tao // Medical Oncology;Dec2011, Vol. 28, p91 

    SET and MYND domain-containing protein 3 (SMYD3) is a histone methyltransferase that plays an important role in transcriptional regulation in human carcinogenesis. It can specifically methylate histone H3 at lysine 4 and activate the transcription of a set of downstream genes, including several...

  • Metastasis: Feeding the beast. Seton-Rogers, Sarah // Nature Reviews Cancer;Mar2015, Vol. 15 Issue 3, p134 

    The article presents studies which examined how manipulation of energy availability by cancer cells that were mediated by changes in microRNAs (miRNAs) can fuel metastatic colonization. It mentions one on the use of in vivo selection of a colon cancer cell line to derive two independent lines...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics